Invention Grant
- Patent Title: Combination therapy for treating HCV infection
- Patent Title (中): 治疗HCV感染的联合疗法
-
Application No.: US12560752Application Date: 2009-09-16
-
Publication No.: US08399484B2Publication Date: 2013-03-19
- Inventor: David Huang , Gerhard Gustav Steinmann , Jerry Oscar Stern
- Applicant: David Huang , Gerhard Gustav Steinmann , Jerry Oscar Stern
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A01N43/78 ; A01N43/36 ; A61K31/47 ; A61K31/425 ; A61K31/40
Abstract:
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
Public/Granted literature
- US20100068182A1 COMBINATION THERAPY FOR TREATING HCV INFECTION Public/Granted day:2010-03-18
Information query
IPC分类:
